FGF2-Based Cyclic Peptide PET Tracer for Noninvasive Detection of FGFR1 Expression in Non-Small Cell Lung Cancer.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- FGF2-Based Cyclic Peptide PET Tracer for Noninvasive Detection of FGFR1 Expression in Non-Small Cell Lung Cancer.
- Published In:
- Journal of medicinal chemistry, 69(4), 4755-4770 (2026)
- Authors:
- Xue, Yan(3), Huang, Zhihong, Zhu, Xue, Wang, Shuang, Jiao, Yang, Wang, Xun, Tang, Jie, Xu, Dong, Zhang, Yongchang, Wang, Qian, Xu, Chunwei, Fang, Jing, Wang, Ke
- Database ID:
- RPEP-16460
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-16460APA
Xue, Yan; Huang, Zhihong; Zhu, Xue; Wang, Shuang; Jiao, Yang; Wang, Xun; Tang, Jie; Xu, Dong; Zhang, Yongchang; Wang, Qian; Xu, Chunwei; Fang, Jing; Wang, Ke. (2026). FGF2-Based Cyclic Peptide PET Tracer for Noninvasive Detection of FGFR1 Expression in Non-Small Cell Lung Cancer.. Journal of medicinal chemistry, 69(4), 4755-4770. https://doi.org/10.1021/acs.jmedchem.5c03417
MLA
Xue, Yan, et al. "FGF2-Based Cyclic Peptide PET Tracer for Noninvasive Detection of FGFR1 Expression in Non-Small Cell Lung Cancer.." Journal of medicinal chemistry, 2026. https://doi.org/10.1021/acs.jmedchem.5c03417
RethinkPeptides
RethinkPeptides Research Database. "FGF2-Based Cyclic Peptide PET Tracer for Noninvasive Detecti..." RPEP-16460. Retrieved from https://rethinkpeptides.com/research/xue-2026-fgf2based-cyclic-peptide-pet
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.